{"created":"2023-06-20T15:54:36.810144+00:00","id":9910,"links":{},"metadata":{"_buckets":{"deposit":"5ec9858e-c7b6-4017-b617-9fcde87082ef"},"_deposit":{"created_by":41,"id":"9910","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"9910"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00009910","sets":["340","340:341","340:341:403"]},"author_link":["34147","34149","34148","34146"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2016-03-31","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"23","bibliographicPageStart":"19","bibliographicVolumeNumber":"20","bibliographic_titles":[{"bibliographic_title":"高知赤十字病院医学雑誌"},{"bibliographic_title":"Medical Journal of Kochi Red Cross Hospital","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"darbepoetin α(DA)を6ヵ月以上使用している維持血液透析患者でepoetin β pegol(C.E.R.A.)への切り替えを31例に行い、その効果と安全性につき検討した。DA<80μg/4週の6例はC.E.R.A.100μg/4週に1回、DA≧80μg/4週の25例はC.E.R.A.150μg/4週に1回で開始し、腎性貧血治療ガイドラインに従い、目標Hb値10〜12g/dlとし、C.E.R.A.の投与量の調節を行い、適宜、鉄剤の投与を行った。投与前のベースラインから、Hb値の増減は1.0g/dl以内であったものがほとんどであった。12ヵ月後では、変更前と比較して、Hb値は統計学的に有意に増加した(Wilcoxon検定、p=0.001)が、24ヵ月では有意差を認めなかった。Hb値が10g/dl以上の維持が可能であった割合は12ヵ月、24ヵ月でそれぞれ、93.5%、96.1%であった。今回の設定量でHb値の変動は少なく、2年の長期でも効果は安定していると、考えられ、月1回投与にて、注射時の感染リスク・誤投与リスク・労力の軽減、医療廃棄物の減少に寄与すると考えられた。(著者抄録)","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"高知赤十字病院図書室運営委員会"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0919-7427","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"田村, 雅人"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"小居, 浩之"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"奈路田, 拓史"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"中村, 章一郎"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2016-07-11"}],"displaytype":"simple","filename":"2015高知赤十字病院医学雑誌-06.pdf","filesize":[{"value":"1.3 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"2015高知赤十字病院医学雑誌-06","url":"https://redcross.repo.nii.ac.jp/record/9910/files/2015高知赤十字病院医学雑誌-06.pdf"},"version_id":"cb8c6861-5611-4d8a-b387-03b5166b9195"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"血液透析患者におけるdarbepoetin αからepoetin β pegolへの切り替え投与の長期成績","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"血液透析患者におけるdarbepoetin αからepoetin β pegolへの切り替え投与の長期成績"}]},"item_type_id":"10001","owner":"41","path":["340","341","403"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-07-11"},"publish_date":"2016-07-11","publish_status":"0","recid":"9910","relation_version_is_last":true,"title":["血液透析患者におけるdarbepoetin αからepoetin β pegolへの切り替え投与の長期成績"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2023-06-20T19:28:19.464600+00:00"}